Immunovant, Inc. ($IMVT)
Filing Information
| Accession Number | 0001764013-26-000024 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 3, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
1,086,689
Total Value
$14,082,475.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 368,750 | $14.46 | $5,332,125.00 | 368,750 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale to Issuer | 334,960 | $25.10 | $8,407,496.00 | 33,790 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 12,820 | $24.04 | $308,192.80 | 20,970 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 1,409 | $24.60 | $34,661.40 | 19,561 | Direct | โ | View Details | |
Director | Capped Value Appreciation Rights | Derivative | Apr 1, 2026 | Exercise/Conversion | 368,750 | $0.00 | $0.00 | 1,106,250 | Direct | โ | View Details |